Skip to main content

ResMed| Q1 FY2027 results

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026 · Market value $33.91B

ResMed| reported revenue of $1.41 billion, up 5.9% from a year earlier, net income of $418 million and diluted earnings per share of $2.92 against $2.37 for the first quarter of fiscal 2027 (the three months to 30 Sep 2026).

From its quarterly report, the results first announced on 29 Oct 2026. Compiled and checked by AapWire.

Q1 FY2027 against Q1 FY2026

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

ResMed| Q1 FY2027 results against the year-ago quarter
MeasureQ1 FY2027Q1 FY2026Change
Revenue$1.41B$1.34B+5.9%
Gross profit$870.6M$817.7M+6.5%
Gross margin61.5%61.2%+0.3 pts
Operating income$453.0M$446.5M+1.4%
Operating margin32.0%33.4%−1.4 pts
Net income$418.4M$348.5M+20.0%
Diluted EPS$2.92$2.37+23.2%
Operating cash flow$422.4M$457.3M−7.6%
Capital expenditure$48.74M$42.97M+13.4%
Free cash flow$373.7M$414.4M−9.8%

Operating KPIs for the quarter

ResMed| operating KPIs, Q1 FY2027
KPIQ1 FY2027Change on a year
Residential Care Software revenue$155.0Mdown 6.7%

Earlier quarters

ResMed| results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q1 FY202730 Sep 2026$1.41B+5.9%$2.92
Q4 FY202630 Jun 2026$1.46B+8.6%$2.64
Q3 FY202631 Mar 2026$1.43B+10.8%$2.74
Q2 FY202631 Dec 2025$1.42B+11.0%$2.68
Q1 FY202630 Sep 2025$1.34B+9.1%$2.37
Q4 FY202530 Jun 2025$1.35B+10.2%$2.58
Q3 FY202531 Mar 2025$1.29B+7.9%$2.48
Q2 FY202531 Dec 2024$1.28B+10.3%$2.34

More on ResMed|: financial statements · revenue · earnings per share

RMD's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.